1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
JemincarePhase 1 NCT06549309 Registry history of NCT06549309 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-30 | NCT07848945 Phase I Study of JY1001 Injection | Phase 1 | Not Yet Recruiting |
| 2026-09-25 | NCT07841093 A Study of JMKX003142 Tablet to Treat Renal Edema | Phase 3 | Not Yet Recruiting |
| Phase 1 | 12 | |
| Phase 2 | 4 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07402213 | Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria. | Chronic Spontaneous Urticaria | Recruiting | 2026-08-03 |
| NCT07841093 | A Study of JMKX003142 Tablet to Treat Renal Edema | Renal Edema | Not Yet Recruiting | 2026-09-30 |
| NCT07242274 | Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic… | NSCLC (Non-small Cell Lung Cancer) | Not Yet Recruiting | 2025-11-21 |
| Phase 2 | ||||
| NCT06800651 | Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant… | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Recruiting | 2025-07-03 |
| NCT06664125 | Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on… | Hyperphosphatemia | Recruiting | 2025-02-03 |
| NCT06509334 | Trial of JYB1904 in Chronic Spontaneous Urticaria. | Chronic Spontaneous Urticaria | Recruiting | 2024-11-29 |
| NCT07459452 | Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis | Perennial Allergic Rhinitis | Not Yet Recruiting | 2026-03-09 |
| Phase 1 | ||||
| NCT07208136 | A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | 2025-12-01 |
| NCT06946927 | A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC… | NSCLC (Advanced Non-small Cell Lung Cancer) | Recruiting | 2025-07-01 |
| NCT06740019 | A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion | Malignant Pleural Effusions (Mpe) | Recruiting | 2025-04-04 |
| NCT06321250 | A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma | Renal Cell Carcinoma Metastatic | Recruiting | 2024-07-09 |
| NCT07848945 | Phase I Study of JY1001 Injection | Pain After Surgery | Not Yet Recruiting | 2026-09-30 |
| NCT07565441 | Drug-Drug Interactions of JMKX003142 in Healthy Participants | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Not Yet Recruiting | 2026-05-04 |
| NCT07513857 | Trial of JYB1904 Injection in Adolescent Participants | Allergic Diseases | Not Yet Recruiting | 2026-04-07 |
| NCT07470177 | A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Not Yet Recruiting | 2026-03-13 |
| NCT07463053 | Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Not Yet Recruiting | 2026-03-10 |
| NCT07181265 | Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Not Yet Recruiting | 2025-09-18 |
| NCT06832657 | Study of JMKX003948 Ophthalmic Suspension in Healthy Participants | Age-Related Macular Degeneration (AMD) | Not Yet Recruiting | 2025-02-18 |
| NCT06658964 | Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects | ADPKD (autosomal Dominant Polycystic Kidney Disease) | Not Yet Recruiting | 2024-10-26 |
Lung Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Kidney Cancer (1)